Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer

We describe a patient with node positive prostate cancer treated with radiation, androgen deprivation, and immunotherapy with long-term overall survival and PSA control. ELISPOT immunoassay studies demonstrated PSA specific T-cells prior to starting vaccine therapy suggesting that this positive resp...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Kamrava, Kwong Y. Tsang, R. A. Madan, A. Kaushal, C. N. Coleman, J. Gulley
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2009/363914
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552462366539776
author M. Kamrava
Kwong Y. Tsang
R. A. Madan
A. Kaushal
C. N. Coleman
J. Gulley
author_facet M. Kamrava
Kwong Y. Tsang
R. A. Madan
A. Kaushal
C. N. Coleman
J. Gulley
author_sort M. Kamrava
collection DOAJ
description We describe a patient with node positive prostate cancer treated with radiation, androgen deprivation, and immunotherapy with long-term overall survival and PSA control. ELISPOT immunoassay studies demonstrated PSA specific T-cells prior to starting vaccine therapy suggesting that this positive response may be related to an improved antitumor immune response of the patient, increased immunogenicity of the tumor, or decreased activation of immune escape pathways. Further evaluation of therapeutic cancer vaccines in combination with radiation and hormonal therapy in the definitive management of prostate cancer is warranted.
format Article
id doaj-art-d411451655bd494da7bc6f26c7b6f20d
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-d411451655bd494da7bc6f26c7b6f20d2025-02-03T05:58:37ZengWileyClinical and Developmental Immunology1740-25221740-25302009-01-01200910.1155/2009/363914363914Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate CancerM. Kamrava0Kwong Y. Tsang1R. A. Madan2A. Kaushal3C. N. Coleman4J. Gulley5Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USALaboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USALaboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USARadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USARadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USALaboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USAWe describe a patient with node positive prostate cancer treated with radiation, androgen deprivation, and immunotherapy with long-term overall survival and PSA control. ELISPOT immunoassay studies demonstrated PSA specific T-cells prior to starting vaccine therapy suggesting that this positive response may be related to an improved antitumor immune response of the patient, increased immunogenicity of the tumor, or decreased activation of immune escape pathways. Further evaluation of therapeutic cancer vaccines in combination with radiation and hormonal therapy in the definitive management of prostate cancer is warranted.http://dx.doi.org/10.1155/2009/363914
spellingShingle M. Kamrava
Kwong Y. Tsang
R. A. Madan
A. Kaushal
C. N. Coleman
J. Gulley
Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
Clinical and Developmental Immunology
title Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
title_full Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
title_fullStr Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
title_full_unstemmed Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
title_short Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer
title_sort long term survival and psa control with radiation and immunotherapy for node positive prostate cancer
url http://dx.doi.org/10.1155/2009/363914
work_keys_str_mv AT mkamrava longtermsurvivalandpsacontrolwithradiationandimmunotherapyfornodepositiveprostatecancer
AT kwongytsang longtermsurvivalandpsacontrolwithradiationandimmunotherapyfornodepositiveprostatecancer
AT ramadan longtermsurvivalandpsacontrolwithradiationandimmunotherapyfornodepositiveprostatecancer
AT akaushal longtermsurvivalandpsacontrolwithradiationandimmunotherapyfornodepositiveprostatecancer
AT cncoleman longtermsurvivalandpsacontrolwithradiationandimmunotherapyfornodepositiveprostatecancer
AT jgulley longtermsurvivalandpsacontrolwithradiationandimmunotherapyfornodepositiveprostatecancer